MassIVE MSV000099316

Complete Public PXD068969

Proteomics analysis of Hydractinia symbiolongicarpus nematocysts

Description

Hydractinia symbiolongicarpus nematocysts were sorted from ca. 120 polyps that had been dissociated in 1% pronase. Two gating strategies were used, a large gate (LG) and a more conservative small gating (SG) strategy to limit the number of dead cells. About 300,000 nematocysts were obtained for both sorting strategies, flash-frozen, and stored at -70C until further use. Nematocysts were lysed through freeze/thaw/sonicate cycles. The tubes were centrifuged at 14,000g for 10 min, and the supernatant was dried using a SpeedVac concentrator (Savant) without heat. The dried protein pellets were stored at -20C. Proteins were solubilized in 30 ul of 8M urea,100mM Tris, pH8.5, vortexed, and sonicated 10 times with 30 sec ON/30 sec OFF cycles in a water bath at RT. Proteins were reduced by adding TCEP at 1M to 5 mM final at RT for 30 min. Reduced cysteine residues were carboxymethylated by adding 5 ul of 0.5M CAM and samples were incubated for 30 min in the dark at RT. Endoproteinase Lys-C at 0.1ug/ul was added at 1:1000 w/w and the digestion proceeded for over 6 hrs at 37C. The sample was diluted to 2M urea with 100mM Tris, pH8.5, 2mM CaCl2, and sequencing grade modified trypsin was added at 1:200 w/w, at 37C O/N. Peptide amounts calculated from a fluorometric assay were ca. 400 and 200 ng for the LG and SG samples, respectively. Peptides were dried using a SpeedVac concentrator. The dried peptide mixture was resuspended in 300 ul of 0.1% trifluoroacetic acid (TFA) and loaded onto one high pH fractionation cartridge placed on a new 2 ml sample tube. After centrifuging at 3000g for 2 min, the eluate was collected as the "flow-through" fraction. The loaded cartridge was placed on a new 2 ml sample tube, washed with 300 ul of ddH20, and the eluate collected as "wash" fraction. A total of 8 HpH RP fractions were collected by sequential elution in new sample tubes using 300 ul of 10%, 12.5%, 15%, 17.5%, 20%, 22.5%, 25%, and 50% acetonitrile in 0.1% TFA. Peptides were analyzed on an Orbitrap Eclipse Tribrid Mass Spectrometer with a FAIMS Pro interface, equipped with a Nanospray Flex Ion Source, and coupled to a Dionex UltiMate 3000 RSCLnano System (U3000). A 75 um i.d. analytical microcapillary column was packed in-house with 250 mm of 1.9 um ReproSil-Pur C18-AQ resin (Dr. Masch). AgileSLEEVE was used to maintain column temperature at 50C. Peptides from each of the 8 HpH RP fractions were solubilized in 22 ul of buffer A (5% acetonitrile in 0.1% formic acid, FA) and loaded via a 20 uL sample loop on an Acclaim PepMap 100 C18 trap cartridge (0.3 mm inner diameter (i.d.), 5 mm length; Thermo Fisher Scientific) with the U3000 loading pump at 2 uL/minute via the autosampler. The organic solvent solutions were water:acetonitrile:formic acid at 95:5:0.1 (volume ratio) for buffer A (pH 2.6) and 20:80:0.1 (volume ratio) for buffer B. Peptides were eluted directly into the mass spectrometer over a 95-min chromatography gradient with a nano pump flow rate set to 0.180 ul/min. The Orbitrap Eclipse was set up to run the MS OT/ddMS2 IT HCD method with two FAIMS CVs at -40V and -60V and a cycle time of 1 sec. Briefly, eluting peptide ions were scanned from 375-1500 m/z in the Orbitrap at 120,000 resolving power before ddMS2 fragmentation by HCD at 35% NCE and detection in the ion trap set to rapid scan rate. The isolation window was 1.6 m/z and dynamic exclusion, with low and high mass tolerances set at 10 ppm, was enabled for 45s. [doi:10.25345/C5B853X13] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: cnidarians ; stinging cells ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order)
Laurence Florens, The Stowers Institute for Medical Research, USA
Submitting User: simrproteomics
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files Browse Results
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.